U.S. Physical Therapy (NYSE:USPH) had its target price hoisted by Cantor Fitzgerald from $103.00 to $107.00 in a research note released on Friday. The brokerage currently has a neutral rating on the stock.
Other research analysts have also recently issued reports about the stock. Zacks Investment Research raised shares of U.S. Physical Therapy from a hold rating to a buy rating and set a $129.00 price target for the company in a report on Tuesday, August 7th. Jefferies Financial Group reissued a hold rating and set a $105.00 price target on shares of U.S. Physical Therapy in a report on Friday, August 3rd. Finally, Barrington Research reissued a hold rating on shares of U.S. Physical Therapy in a report on Friday, August 3rd. Four research analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of Buy and a consensus target price of $113.67.
NYSE USPH traded down $2.56 during trading hours on Friday, hitting $113.00. 113,897 shares of the stock were exchanged, compared to its average volume of 94,362. The stock has a market capitalization of $1.43 billion, a P/E ratio of 46.69, a P/E/G ratio of 3.98 and a beta of 1.19. U.S. Physical Therapy has a 12-month low of $64.45 and a 12-month high of $129.65. The company has a quick ratio of 2.06, a current ratio of 1.93 and a debt-to-equity ratio of 0.26.
U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, November 1st. The company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.06. The firm had revenue of $113.10 million during the quarter, compared to analysts’ expectations of $112.79 million. U.S. Physical Therapy had a net margin of 5.58% and a return on equity of 17.64%. The firm’s quarterly revenue was up 9.8% compared to the same quarter last year. On average, equities research analysts expect that U.S. Physical Therapy will post 2.54 earnings per share for the current fiscal year.
The business also recently announced a dividend, which will be paid on Friday, December 7th. Shareholders of record on Friday, November 9th will be issued a $0.23 dividend. The ex-dividend date is Thursday, November 8th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 44.23%.
In other U.S. Physical Therapy news, Director Jerald L. Pullins sold 4,000 shares of the stock in a transaction dated Monday, August 6th. The shares were sold at an average price of $115.01, for a total value of $460,040.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Mark J. Brookner sold 2,500 shares of the stock in a transaction dated Friday, September 21st. The shares were sold at an average price of $116.00, for a total transaction of $290,000.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,750 shares of company stock valued at $2,642,402. 2.50% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently modified their holdings of USPH. Acadian Asset Management LLC acquired a new stake in shares of U.S. Physical Therapy in the second quarter valued at approximately $106,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of U.S. Physical Therapy in the third quarter valued at approximately $190,000. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of U.S. Physical Therapy in the second quarter valued at approximately $219,000. Itau Unibanco Holding S.A. acquired a new stake in shares of U.S. Physical Therapy in the second quarter valued at approximately $235,000. Finally, PNC Financial Services Group Inc. grew its position in shares of U.S. Physical Therapy by 62.7% in the second quarter. PNC Financial Services Group Inc. now owns 2,676 shares of the company’s stock valued at $256,000 after purchasing an additional 1,031 shares during the last quarter. 97.61% of the stock is owned by institutional investors.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Article: Risk Tolerance and Your Investment Decisions
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.